XML 21 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Details    
Sales $ 0 $ 0
Total Sales 0 0
Operating Expenses    
Research and development 302,328 60,332
General and administrative 110,550 137,224
Impairment of property and equipment 389,000 0
Total Operating Expenses 801,878 197,556
Operating Loss (801,878) (197,556)
Interest expense 0 (120)
Loss before loss from discontinued operations (801,878) (197,676)
Discontinued operations 6,858 0
Net loss $ (795,020) $ (197,676)
Basic and Diluted Loss per Share - Continuing Operations $ (0.01) $ (0.00)
Basic and Diluted Loss per Share - Discontinued Operations 0.00 (0.00)
Basic and Diluted Loss per Share - Net Loss $ (0.01) $ (0.00)
Basic and Diluted Weighted-Average Common Shares Outstanding 100,000,000 100,000,000